Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Gender differences should be considered to boost motivation in female municipal workers.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

JOLT uses fillers to lift and tighten the lower face and neck.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Lablab purpureus peptides may effectively kill cancer cells with fewer side effects.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

The document concludes that improving patient safety and quality is increasingly important in dermatology.

Several doctors received research grants, new workshops and conferences were announced, and new officers were elected.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Corporations should adopt open innovation with community ideas to address social needs and empower communities.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

PRP therapy's success varies and depends on PRP quality and patient condition, with athletes benefiting more.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.